Transcutaneous Electrical Muscle Stimulation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

The University Clinic of Pulmonary and Allergic Diseases Golnik1 site in 1 country19 target enrollmentJanuary 2009

ConditionsChronic Obstructive Pulmonary Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Obstructive Pulmonary Disease
Sponsor: The University Clinic of Pulmonary and Allergic Diseases Golnik
Enrollment: 19
Locations: 1
Primary Endpoint: Scores on the feasibility scale
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease.

The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.

Registry

clinicaltrials.gov

Start Date

January 2009

End Date

October 2009

Last Updated

13 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

The University Clinic of Pulmonary and Allergic Diseases Golnik

Responsible Party

Principal Investigator

Mitja Lainščak

Professor

The University Clinic of Pulmonary and Allergic Diseases Golnik

Eligibility Criteria

Inclusion Criteria

•chronic obstructive pulmonary disease GOLD stage III or IV
•acute exacerbation of the disease

Exclusion Criteria

•contraindications for transcutaneous electrical muscle stimulation

Outcomes

Primary Outcomes

Scores on the feasibility scale

Time Frame: 10 days (avarage time from admission to discharge)

Patients will be followed from admission until discharge

Secondary Outcomes

Scores on the patient satisfaction scale(10 days (avarage time from admission to discharge))
Number of patients with adverse events as a measure of Safety and tolerability(10 days (avarage time from admission to discharge))
Health related quality of life on the St. George respiratory questionnaire(10 days (avarage time from admission to discharge))
Dyspnea on the MRC dyspnea scale(10 days (avarage time from admission to discharge))
Patient symptom scores on the Functional assessment of chronic illness therapy questionaire(10 days (avarage time from admission to discharge))